Contact tracing of COVID-19 in Karnataka, India: Superspreading and determinants of infectiousness and symptomatic infection

Author:

Gupta MohakORCID,Parameswaran Giridara G.,Sra Manraj S.ORCID,Mohanta RishikaORCID,Patel Devarsh,Gupta AmulyaORCID,Bansal BhavikORCID,Jain Vardhmaan,Mazumder ArchismanORCID,Arora Mehak,Aggarwal Nishant,Bhatnagar Tarun,Akhtar Jawaid,Pandey Pankaj,Ravi Vasanthapuram,Babu Giridhara R.ORCID

Abstract

Background India has experienced the second largest outbreak of COVID-19 globally, yet there is a paucity of studies analysing contact tracing data in the region which can optimise public health interventions (PHI’s). Methods We analysed contact tracing data from Karnataka, India between 9 March and 21 July 2020. We estimated metrics of transmission including the reproduction number (R), overdispersion (k), secondary attack rate (SAR), and serial interval. R and k were jointly estimated using a Bayesian Markov Chain Monte Carlo approach. We studied determinants of risk of further transmission and risk of being symptomatic using Poisson regression models. Findings Up to 21 July 2020, we found 111 index cases that crossed the super-spreading threshold of ≥8 secondary cases. Among 956 confirmed traced cases, 8.7% of index cases had 14.4% of contacts but caused 80% of all secondary cases. Among 16715 contacts, overall SAR was 3.6% [95% CI, 3.4–3.9] and symptomatic cases were more infectious than asymptomatic cases (SAR 7.7% vs 2.0%; aRR 3.63 [3.04–4.34]). As compared to infectors aged 19–44 years, children were less infectious (aRR 0.21 [0.07–0.66] for 0–5 years and 0.47 [0.32–0.68] for 6–18 years). Infectors who were confirmed ≥4 days after symptom onset were associated with higher infectiousness (aRR 3.01 [2.11–4.31]). As compared to asymptomatic cases, symptomatic cases were 8.16 [3.29–20.24] times more likely to cause symptomatic infection in their secondary cases. Serial interval had a mean of 5.4 [4.4–6.4] days, and case fatality rate was 2.5% [2.4–2.7] which increased with age. Conclusion We found significant heterogeneity in the individual-level transmissibility of SARS-CoV-2 which could not be explained by the degree of heterogeneity in the underlying number of contacts. To strengthen contact tracing in over-dispersed outbreaks, testing and tracing delays should be minimised and retrospective contact tracing should be implemented. Targeted measures to reduce potential superspreading events should be implemented. Interventions aimed at children might have a relatively small impact on reducing transmission owing to their low symptomaticity and infectivity. We propose that symptomatic cases could cause a snowballing effect on clinical severity and infectiousness across transmission generations; further studies are needed to confirm this finding.

Funder

The Wellcome Trust DBT India Alliance

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference53 articles.

1. The origin of SARS-CoV-2—The Lancet Infectious Diseases. at

2. COVID-19 Map—Johns Hopkins Coronavirus Resource Center [Internet]. [cited 2020 Sep 23]. https://coronavirus.jhu.edu/map.html

3. Karnataka Government [Internet]. [cited 2020 Nov 10]. https://karnataka.gov.in/info-1/State+Indicators/%E0%B2%9C%E0%B2%A8%E0%B2%B8%E0%B2%82%E0%B2%96%E0%B3%8D%E0%B2%AF%E0%B3%86/en

4. “A Menace to the Public Health”—Contact Tracing and the Limits of Persuasion \textbar NEJM [Internet]. [cited 2020 Sep 30]. https://www.nejm.org/doi/10.1056/NEJMp2021887?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

5. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts;J Hellewell;The Lancet Global Health,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3